Table 4 The specific situation of 12 clusters
From: The status of and trends in the pharmacology of berberine: a bibliometric review [1985–2018]
Cluster ID | Size | Silhouette | Mean year | Cluster label |
|---|---|---|---|---|
0 | 46 | 0.747 | 2008 | Gata |
1 | 46 | 0.66 | 2007 | Pharmacokinetics |
2 | 44 | 0.793 | 2000 | Coralyne |
3 | 31 | 0.941 | 1995 | Antipyretic |
4 | 31 | 0.867 | 2014 | Pi3k-akt |
5 | 30 | 0.788 | 2006 | Reactive oxygen species |
6 | 24 | 0.839 | 2008 | Erk signaling pathway |
7 | 23 | 0.817 | 2012 | Neuroinflammation |
8 | 17 | 0.813 | 2003 | Vascular smooth muscle cell |
9 | 14 | 0.903 | 2010 | Hypoglycemic |
10 | 10 | 0.889 | 1999 | Therapeutic effect |
11 | 8 | 0.934 | 1997 | Superoxide dismutase |